Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?
Schäfgen B, Haller A, Sinn HP, Feisst M, Gomez C, Stieber A, Nees J, Togawa R, Pfob A, Hennigs A, Hederer J, Riedel F, Fastner S, Heil J, Golatta M. Schäfgen B, et al. Among authors: riedel f. Breast Cancer Res Treat. 2023 Aug;201(1):57-66. doi: 10.1007/s10549-023-06976-2. Epub 2023 Jun 11. Breast Cancer Res Treat. 2023. PMID: 37302085 Free PMC article.
Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners.
Maier A, Heil J, Lauer A, Harcos A, Schaefgen B, von Au A, Spratte J, Riedel F, Rauch G, Hennigs A, Domschke C, Schott S, Rom J, Schuetz F, Sohn C, Golatta M. Maier A, et al. Among authors: riedel f. Arch Gynecol Obstet. 2017 Sep;296(3):571-582. doi: 10.1007/s00404-017-4473-y. Epub 2017 Jul 26. Arch Gynecol Obstet. 2017. PMID: 28748340
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
Heil J, Sinn P, Richter H, Pfob A, Schaefgen B, Hennigs A, Riedel F, Thomas B, Thill M, Hahn M, Blohmer JU, Kuemmel S, Karsten MM, Reinisch M, Hackmann J, Reimer T, Rauch G, Golatta M. Heil J, et al. Among authors: riedel f. BMC Cancer. 2018 Aug 25;18(1):851. doi: 10.1186/s12885-018-4760-4. BMC Cancer. 2018. PMID: 30144818 Free PMC article. Clinical Trial.
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A, Köpke M, Feißt M, Riedel F, Rezai M, Nitz U, Moderow M, Golatta M, Sohn C, Schneeweiss A, Heil J. Hennigs A, et al. Among authors: riedel f. Breast Cancer Res Treat. 2019 Jan;173(2):429-438. doi: 10.1007/s10549-018-5009-2. Epub 2018 Oct 12. Breast Cancer Res Treat. 2019. PMID: 30315437
277 results